Sotera Health Company (NASDAQ:SHC) Q1 2023 Earnings Conference Call May 3, 2023 8:30 AM ET
Company Participants
Jason Peterson - Vice President and Treasurer
Michael Petras - Chairman and Chief Executive Officer
Michael Biehl - Interim Chief Financial Officer
Conference Call Participants
Elizabeth Speyer - Citi
Michael Polark - Wolfe Research
Sean Dodge - RBC Capital Markets
Luke Sergott - Barclays
David Windley - Jefferies
Casey Woodring - J.P. Morgan
Matthew Mishan - KeyBanc Capital Markets
Operator
Good morning, and welcome to the Sotera Health First Quarter 2023 Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Vice President and Treasurer, Jason Peterson. Please go ahead.
Jason Peterson
Good morning, and thank you. Welcome to Sotera Health's first quarter 2023 results call. You can find today's press release and accompanying supplemental slides on the Investors section of our website at soterahealth.com. This webcast is being recorded and a replay will be available in the Investors section of Sotera Health website. On the call with me today are Chairman and Chief Executive Officer, Michael Petras; and Interim Chief Financial Officer, Michael Biehl.
During the call, some of our comments may be considered forward-looking statements. The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to Sotera Health's SEC filings and the forward-looking statements slide at the beginning of this presentation for a description of these risks and uncertainties. The company assumes no obligation to update any such forward-looking statements.
Please note that during the discussion today, the company will present both GAAP and non-GAAP financial measures, including adjusted net income, adjusted EBITDA, adjusted EPS, net debt, adjusted EBITDA margin and net leverage ratio in addition to constant currency comparisons. A reconciliation of GAAP to non-GAAP measures for all relevant periods may be found in the schedules attached to the company's press release and in the supplemental slides of this presentation.
The operator will be assisting with the Q&A portion of the call today. Please limit yourself to one question and one follow-up so that we can give everyone an opportunity to ask questions. As always, if you have any questions, post call, please feel free to reach out to me and the Investor Relations team.
I will now turn the call over to Sotera Health Chairman and CEO, Michael Petras.